Exploring the Potential Applications of QRICH2: A Glutamine-Rich Protein 2 Isoform as a Drug Target or Biomarker

Target Name: QRICH2

NCBI ID: G84074

QRICH2

Exploring the Potential Applications of QRICH2: A Glutamine-Rich Protein 2 Isoform as a Drug Target or Biomarker

Introduction

QRICH2, or Glutamine-rich protein 2 isoform 1, is a protein that has gained significant interest in recent years due to its potential roles in various biological processes. One of its key functions is its role in cell signaling, where it acts as a scaffold to regulate protein-protein interactions and play a crucial role in the assembly and disassembly of protein complexes.

Recent studies have also suggested that QRICH2 may have potential as a drug target or biomarker. In this article, we will delve into the research on QRICH2 and explore its potential applications in these areas.

The QRICH2 Protein

QRICH2 is a member of the QRCH2 family, which is known for its role in regulating protein-protein interactions and involved in various cellular processes, including cell signaling, cytoskeletal organization, and intracellular transport. The QRICH2 protein is composed of 198 amino acid residues and has a calculated molecular mass of 21.1 kDa.

One of the key features of QRICH2 is its ability to form a stable protein-protein complex with other proteins. This is achieved through its conserved helical structure, which allows for the formation of a well-defined interface between the protein partners.

In cellular signaling, QRICH2 plays a crucial role in regulating protein interactions and in the assembly and disassembly of protein complexes. For example, it has been shown to interact with the proteinBeclin-1 (BECN1), which is involved in the regulation of cell growth , apoptosis, and autophagy.

In addition to its role in cell signaling, QRICH2 has also been suggested as a potential biomarker for various diseases. For example, it has been shown to be expressed in various human tissues, including brain, heart, liver, and muscle, and has been linked to various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

The Potential Applications of QRICH2 as a Drug Target

The potential applications of QRICH2 as a drug target are vast and span across various therapeutic areas. Here are some of the potential targets for QRICH2:

1.Cancer

QRICH2 has been shown to be involved in the regulation of cell cycle progression and has been linked to the development and progression of various cancers. For example, studies have shown that high levels of QRICH2 are associated with poor prognosis in cancer patients.

2. Neurodegenerative Diseases

QRICH2 has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Studies have shown that QRICH2 is expressed in the brains of patients with these conditions and that its levels are decreased in the brains of individuals with these conditions.

3. Autoimmune Diseases

QRICH2 has also been suggested as a potential target for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Studies have shown that individuals with these conditions have lower levels of QRICH2 and that treatments that increase QRICH2 levels may be effective in reducing the symptoms of these conditions.

4. Cardiovascular Disease

QRICH2 has also been shown to be involved in the regulation of cardiovascular disease, including hypertension and heart failure. Studies have shown that individuals with these conditions have lower levels of QRICH2 and that treatments that increase QRICH2 levels may be effective in reducing the symptoms of these conditions.

The Potential Applications of QRICH2 as a Biomarker

The potential applications of QRICH2 as a biomarker are also vast and span across various medical conditions. Here are some of the potential biomarkers for QRICH2:

1.Cancer

QRICH2has

Protein Name: Glutamine Rich 2

Functions: Has an essential role in the formation of sperm flagella and flagellar structure maintainance. It acts as a suppressor of ubiquitination and degradation of proteins involved in flagellar development and motility

The "QRICH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about QRICH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets